Get the Stockscreener App
4.94
2.70%
0.13
After Hours:
4.94
Clover Health Investments Corp stock is traded at $4.94, with a volume of 8.09M.
It is up +2.70% in the last 24 hours and up +42.36% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$4.81
Open:
$4.82
24h Volume:
8.09M
Relative Volume:
1.13
Market Cap:
$2.60B
Revenue:
$2.21B
Net Income/Loss:
$-56.94M
P/E Ratio:
-43.95
EPS:
-0.1124
Net Cash Flow:
$54.54M
1W Performance:
+15.15%
1M Performance:
+42.36%
6M Performance:
+87.12%
1Y Performance:
+69.18%
1-Day Range:
$4.805
$5.06
1-Week Range:
$4.50
$5.18
52-Week Range:
$1.58
$5.18
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
4.94 | 2.53B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
407.65 | 373.28B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
100.72 | 128.46B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
397.80 | 87.28B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
291.88 | 77.73B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
369.49 | 45.65B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Clover Health (NASDAQ: CLOV) RSU vesting lists 5,342 Class A shares for sale - Stock Titan
Clover Health (NASDAQ: CLOV) files Form 144 for 7,556 vested shares - Stock Titan
Clover Health gets Medicare star rating upgrade - MSN
Clover Health Stockholders Approve Directors and Executive Pay - TipRanks
Clover Health (CLOV) stockholders approve directors, pay and 2026 auditor - Stock Titan
Insider Sell: Jamie Reynoso Sells Shares of Clover Health Investments Corp - GuruFocus
Clover Health CEO Jamie Reynoso sells $35,788 of CLOV common stock - Investing.com India
CLOV Maintained by UBS -- Price Target Raised to $4.75 - GuruFocus
Clover Health (NASDAQ: CLOV) exec sells 7,289 shares under 10b5-1 plan - Stock Titan
[144] CLOVER HEALTH INVESTMENTS, CORP. /DE SEC Filing - Stock Titan
Health Care Notes: Clover star rating raised after court-ordered recalculation - InsuranceNewsNet
Clover Health (CLOV) Stock Jumps 14% on Medicare Star Rating Boost to 4.5 - Blockonomi
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating - Benzinga
Clover Health Up Again After CMS Star Rating Shift Alters 2027 Payment View - TechStock²
Top Biotech Gainers: PBLS Soars Over 50%, CLOV Rallies On Legal Win, RNAZ, TMCI On Watch - RTTNews
Clover Health (CLOV)Hits Fresh Peak on Unexpected CMS Rating - Insider Monkey
Clover Health (CLOV) Sees Notable Increase in Share Price - GuruFocus
Clover Health (CLOV) Sees 10% Surge After Medicare Star Rating U - GuruFocus
CLOV: Clover Health Wins Legal Battle, Receives Boost in Star Ra - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Why is Clover Health Investments stock surging today? By Investing.com - Investing.com India
A Court Order Sent CLOV Stock To Over 4.5-Year Highs – Retail Says The Implications Could Be Industry-Wide - Yahoo Finance
Clover Health stock jumps after Medicare rating upgrade - Investing.com
Caseys General Stores Upbeat Q4 Earnings, Joins Applied Optoelectronics, Clover Health Investments And Ot - Benzinga
Clover Health gets Medicare Star Rating upgrade (CLOV:NASDAQ) - Seeking Alpha
Clover Health stock jumps after Medicare rating upgrade By Investing.com - Investing.com Australia
Clover Health Investments sees PPO Star rating revised to 4.5 Stars after court order - TradingView
[8-K] CLOVER HEALTH INVESTMENTS, CORP. /DE Reports Material Event - Stock Titan
Spotlight On Promising Penny Stocks For June 2026 - Yahoo Finance
Clover Health stock hits 52-week high at 4.24 USD By Investing.com - Investing.com India
5 Stocks Surviving Market Slaughter - Insider Monkey
Clover Health stock hits 52-week high at 4.24 USD - Investing.com
3 Growth Stocks With High Insider Ownership And 29% Revenue Growth - simplywall.st
Clover targets 100-150 bps SG&A improvement in 2026 while expecting full-year GAAP net income profitability - MSN
Clover Health in the spotlight as earnings test profitability path - Investing.com
A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors? - The Motley Fool
A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors? - The Motley Fool
Earnings call transcript: Clover Health Q1 2026 sees revenue beat, EPS miss - Investing.com
Clover Health Q1 2026 slides: revenue surges 62%, profitability returns - Investing.com
Clover Health in the spotlight as earnings test profitability path By Investing.com - Investing.com Nigeria
CLOV Maintained by Canaccord Genuity -- Price Target Raised to $4.20 - GuruFocus
Why Clover Health (CLOV) Stock Is Up Today - Barchart
Clover Health Investments (BSP:CLOV34) Cyclically Adjusted PS Ratio : (As of Jun. 03, 2026) - GuruFocus
Clover Health Investments Corp (BSP:CLOV34) Stock Earnings Transcripts - GuruFocus
Breaking News: Rosen, Global Investor Counsel, Encourages Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III Investors with Losses over $100K to Secure Counsel Before Important DeadlineCLOV, CLOVW, IPOC - TMX Newsfile
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clover Health Investments Corp Stock (CLOV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Reynoso Jamie L. | CEO, Medicare Advantage |
Jun 15 '26 |
Sale |
4.61 |
6,350 |
29,274 |
2,843,571 |
4.15%
1.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):